Natus Medical Incorporated (NTUS) Q3 2020 Earnings Call Transcript
NTUS earnings call for the period ending September 30, 2020.
Natus Medical
NTUS
NTUS
$27.30
$0.05
0.2%
Price as of January 26, 2021, 9:00 p.m. EST
View Interactive NTUS Charts
A provider of healthcare products used for screening, detection, treatment, monitoring & tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, newborn jaundice & newborn metabolic testing.
Interactive Chart
News & Analysis: Natus Medical
The Fool has written over 100 articles on Natus Medical.
Natus Medical Incorporated (NTUS) Q2 2020 Earnings Call Transcript
NTUS earnings call for the period ending June 30, 2020.
Is Natus Medical Stock a Buy?
What should investors think of this infant care and neurology specialist?
Natus Medical (NTUS) Q1 2020 Earnings Call Transcript
NTUS earnings call for the period ending March 31, 2020.
Here's Why NuVasive, Exelixis, and Natus Medical Fell Today
The healthcare companies couldn't sidestep the COVID-19 slump.
Natus Medical (NTUS) Q4 2019 Earnings Call Transcript
NTUS earnings call for the period ending December 31, 2019.
Natus Medical (NTUS) Q3 2019 Earnings Call Transcript
NTUS earnings call for the period ending September 30, 2019.
Natus Medical Is All Grown Up
This baby has a new ticker.
Natus Medical Inc (BABY) Q2 2019 Earnings Call Transcript
BABY earnings call for the period ending June 30, 2019.
Natus Medical Continues Its Restructuring
It's a rebuilding year for the medical device maker.
![natusnewbornscreening_large1_large1_large1_large[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F200902%2Fnatusnewbornscreening_large1_large1_large1_large1.png&w=479&h=281&op=resize)
